104. Zhang L et al (2018) Impacts of design configuration and plants on the functionality of the
microbial community of mesocosm-scale constructed wetlands treating ibuprofen. Water Res
131:228–238
105. Matamoros V, Bayona JM (2006) Elimination of pharmaceuticals and personal care products
in subsurface flow constructed wetlands. Environ Sci Technol 40(18):5811–5816
106. Harner T, Wiberg K, Norstrom R (2000) Enantiomer fractions are preferred to enantiomer
ratios for describing chiral signatures in environmental analysis. Environ Sci Technol 34
(1):218–220
107. Lv T et al (2017) Enantioselective uptake, translocation and degradation of the chiral pesticides tebuconazole and imazalil by Phragmites australis. Environ Pollut 229:362–370
108. EC (2019) Communication from the Commission to the European Parliament, the European
Council, the Council, the European Economic and Social Committee and the Committee of the
Regions The European Green Deal COM/2019/640 final
109. Krull W et al (2015) Towards an EU research and innovation policy agenda for nature-based
solutions and re-naturing cities. Final report of the Horizon 2020 expert group on ‘Naturebased solutions and re-naturing cities’
110. Zhang Y et al (2017) Ibuprofen and iohexol removal in saturated constructed wetland
mesocosms. Ecol Eng 98:394–402
111. Fatta-Kassinos D et al (2015) COST action ES1403: new and emerging challenges and
opportunities in wastewater REUSe (NEREUS). Environ Sci Pollut Res 22(9):7183–7186
112. Hollender J et al (2019) High resolution mass spectrometry-based non-target screening can
support regulatory environmental monitoring and chemicals management. Environ Sci Eur 31
(1):42
113. Sörengård M et al (2019) Mass loads, source apportionment, and risk estimation of organic
micropollutants from hospital and municipal wastewater in recipient catchments.
Chemosphere 234:931–941
114. Kosonen J, Kronberg L (2009) The occurrence of antihistamines in sewage waters and in
recipient rivers. Environ Sci Pollut Res 16(5):555–564
115. Schaider LA, Rodgers KM, Rudel RA (2017) Review of organic wastewater compound
concentrations and removal in onsite wastewater treatment systems. Environ Sci Technol 51
(13):7304–7317
116. Lajeunesse A et al (2012) Distribution of antidepressant residues in wastewater and biosolids
following different treatment processes by municipal wastewater treatment plants in Canada.
Water Res 46(17):5600–5612
Constructed Wetlands and Phytoremediation as a Tool for Pharmaceutical Removal
413
microbial community of mesocosm-scale constructed wetlands treating ibuprofen. Water Res
131:228–238
105. Matamoros V, Bayona JM (2006) Elimination of pharmaceuticals and personal care products
in subsurface flow constructed wetlands. Environ Sci Technol 40(18):5811–5816
106. Harner T, Wiberg K, Norstrom R (2000) Enantiomer fractions are preferred to enantiomer
ratios for describing chiral signatures in environmental analysis. Environ Sci Technol 34
(1):218–220
107. Lv T et al (2017) Enantioselective uptake, translocation and degradation of the chiral pesticides tebuconazole and imazalil by Phragmites australis. Environ Pollut 229:362–370
108. EC (2019) Communication from the Commission to the European Parliament, the European
Council, the Council, the European Economic and Social Committee and the Committee of the
Regions The European Green Deal COM/2019/640 final
109. Krull W et al (2015) Towards an EU research and innovation policy agenda for nature-based
solutions and re-naturing cities. Final report of the Horizon 2020 expert group on ‘Naturebased solutions and re-naturing cities’
110. Zhang Y et al (2017) Ibuprofen and iohexol removal in saturated constructed wetland
mesocosms. Ecol Eng 98:394–402
111. Fatta-Kassinos D et al (2015) COST action ES1403: new and emerging challenges and
opportunities in wastewater REUSe (NEREUS). Environ Sci Pollut Res 22(9):7183–7186
112. Hollender J et al (2019) High resolution mass spectrometry-based non-target screening can
support regulatory environmental monitoring and chemicals management. Environ Sci Eur 31
(1):42
113. Sörengård M et al (2019) Mass loads, source apportionment, and risk estimation of organic
micropollutants from hospital and municipal wastewater in recipient catchments.
Chemosphere 234:931–941
114. Kosonen J, Kronberg L (2009) The occurrence of antihistamines in sewage waters and in
recipient rivers. Environ Sci Pollut Res 16(5):555–564
115. Schaider LA, Rodgers KM, Rudel RA (2017) Review of organic wastewater compound
concentrations and removal in onsite wastewater treatment systems. Environ Sci Technol 51
(13):7304–7317
116. Lajeunesse A et al (2012) Distribution of antidepressant residues in wastewater and biosolids
following different treatment processes by municipal wastewater treatment plants in Canada.
Water Res 46(17):5600–5612
Constructed Wetlands and Phytoremediation as a Tool for Pharmaceutical Removal
413